Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Inari Medical, Inc. | 5,745,542 | reported | 27 May 2020 | tx 4+5,745,542−5,745,542 |
| CRISPR Therapeutics AG | 1,539,576 | reported | 23 Apr 2018 | tx 8+92,918−694,912 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 27 May 2020 | CONVERSION | Inari Medical, Inc. | 5,745,542 | — | |
| 27 May 2020 | CONVERSION | Inari Medical, Inc. | 977,058 | — | deriv |
| 27 May 2020 | CONVERSION | Inari Medical, Inc. | 1,197,058 | — | deriv |
| 27 May 2020 | CONVERSION | Inari Medical, Inc. | 3,571,426 | — | deriv |
| 20 Apr 2018 | OTHER | CRISPR Therapeutics AG | 497,053 | 0.00 USD | |
| 23 Apr 2018 | SALE | CRISPR Therapeutics AG | 6,821 | 50.66 USD | |
| 23 Apr 2018 | SALE | CRISPR Therapeutics AG | 2,915 | 51.00 USD | |
| 23 Apr 2018 | SALE | CRISPR Therapeutics AG | 2,630 | 51.00 USD | |
| 23 Apr 2018 | SALE | CRISPR Therapeutics AG | 89,628 | 50.66 USD | |
| 20 Apr 2018 | OTHER | CRISPR Therapeutics AG | 92,918 | 0.00 USD | |
| 20 Apr 2018 | OTHER | CRISPR Therapeutics AG | 92,918 | 0.00 USD | |
| 20 Apr 2018 | OTHER | CRISPR Therapeutics AG | 2,947 | 0.00 USD |